Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party

To assess the effect of age on response and compliance to treatment in patients with chronic myeloid leukemia (CML) we performed a sub-analysis within a phase II trial of the GIMEMA CML Working Party (CML/002/STI571). Since the WHO cut-off age to define an older patient is 65 years, among the 284 pa...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Gianantonio Rosti, Ilaria Iacobucci, Simona Bassi, Fausto Castagnetti, Marilina Amabile, Daniela Cilloni, Angela Poerio, Simona Soverini, Francesca Palandri, Giovanna Rege Cambrin, Franco Iuliano, Giuliana Alimena, Roberto Latagliata, Nicoletta Testoni, Fabrizio Pane, Giuseppe Saglio, Michele Baccarani, Giovanni Martinelli
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Ferrata Storti Foundation 2007-01-01
Seri Bilgileri:	Haematologica
Online Erişim:	https://haematologica.org/article/view/4282
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party

Benzer Materyaller